Login / Signup

The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial.

Toshiaki OhkumaJohn ChalmersMark CooperPavel HametStephen HarrapMichel MarreGiuseppe ManciaNeil PoulterMark Woodward
Published in: Diabetes, obesity & metabolism (2021)
Our results suggest that an intensive glycaemic control strategy to reduce HbA1c to 48 mmol/mol (6.5%) provided broadly similar benefits and harms and may be recommended for older, as well as younger, patients.
Keyphrases